ABC Compounding Recalls Lynx Antiseptic Handsoap Due to CGMP Deviations
ABC Compounding Co., Inc. is voluntarily recalling 9,252 bottles of Lynx peachy-foam antiseptic handsoap nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations, and the source does not report any illnesses, injuries, or deaths.
Plain-English summary
ABC Compounding Co., Inc. is voluntarily recalling 9,252 bottles of Lynx, LX0864 peachy-foam antiseptic handsoap, 1000 ML (33.8 FL OZ.). The product was distributed nationwide in the United States. The recall was initiated by the firm on September 22, 2026, and is currently ongoing.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The FDA has classified this recall as Class II, which indicates that use of or exposure to the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
The source text does not report any illnesses, injuries, or deaths associated with this product. Consumers should stop using the recalled product and contact ABC Compounding Co., Inc. for further instructions or a refund.
The recalled product
- Product
- Lynx, LX0864 peachy-foam antiseptic handsoap, 1000 ML (33.8 FL OZ.) Manufactured by: ABC Compounding Co., INC., 2500 Dogwood Dr., Conyers, GA 30013, UPC 711808210804.
- Manufacturer
- ABC Compounding Co., Inc.
- Category
- Drug — Topical Antiseptic
- Hazard
- Affected units
- 9,252
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 9252 bottles
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · ABC Compounding Co., Inc.
See all →- ModerateABC Compounding Recalls Wechem Hand Guard Bags Due to CGMP Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Antiseptic Hand Soap Due to Manufacturing Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Spurrier Antimicrobial Hand Soap Due to CGMP Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Freshhands Foamy Antibacterial Hand Soap
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Aerocare Sani Mango Antiseptic Hand and Body Wash
FDA (Drugs) · 2026-11-04
Same hazard · cgmp deviation
See all →- ModerateABC Compounding Recalls Chemseptic Due to Manufacturing Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Pro Chem Suds Hand Soap Due to CGMP Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls PRO CHEM BAN AID Antiseptic Hand Soap
FDA (Drugs) · 2026-11-04
- ModeratePalm Antiseptic Hand Soap Recalled for CGMP Deviations
FDA (Drugs) · 2026-11-04
Similar recalls
- ModerateFDA Recalls 2,552 Bottles of Lynx Antibacterial Hand Soap
FDA (Drugs) · 2026-11-04
- ModerateLynx Antibacterial Hand Soap Recalled for CGMP Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Antiseptic Hand Soap Due to Manufacturing Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Freshhands Foamy Antibacterial Hand Soap
FDA (Drugs) · 2026-11-04
- ModeratePalm Antiseptic Hand Soap Recalled for CGMP Deviations
FDA (Drugs) · 2026-11-04
- ModerateABC Compounding Recalls Wechem Hand Guard Bags Due to CGMP Deviations
FDA (Drugs) · 2026-11-04